Recent News
May 23, 2018

Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac...

May 14, 2018

Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac...

May 8, 2018

Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac...

 

Zynex Inc. was founded in 1996 on the principle that a commitment to high-quality patient life through non-invasive rehabilitation products can be a profitable as well as rewarding endeavor.

Today, Zynex is a leading provider of electrotherapy medical devices used for pain management and rehabilitation. The company’s proprietary NeuroMove device is used to help recovery of stroke and spinal cord injury patients. Zynex is also pioneering development of an innovative blood volume monitor for use in hospitals and surgery centers. Zynex is committed to improve the quality of life of patients in the markets it serves by providing the highest technology and service standards available in the industry.

 

OTCQBZYXI
Stock Info
OTCQBZYXI
Amato and Partners, LLC

Investor Relations Counsel

90 Park Avenue, 17th Floor

New York, NY 10016

admin@amatoandpartners.com

Zynex, Inc.

Dan Moorhead

Chief Financial Officer

Telephone: (800) 495-6670 ext. 3322

dmoorhead@zynex